Cumulative dose-response curves to carbachol given by aerosol were established using plethysmographic measurements of specific airways resistance (SRaw) in 10 patients with asthma and five healthy subjects. Two experiments were performed-a control test and one in which maximal respiratory manoeuvres (MRM) (two maximal inspirations and two maximal expirations) were made before each carbachol inhalation. MRM did not modify the dose-response curves in the normal subjects. In the patients these manoeuvres enhanced the bronchoconstrictor effect of carbachol: curves were shifted to the left and the mean dose of carbachol producing a twofold increase in initial SRaw was decreased from 0 373 mg to 0 189 mg (P <0 001). Bronchial provocation tests using methods which require MRM-for example, forced expiratory volume at one second-could overestimate the bronchial sensitivity of patients with asthma.
Introduction
Since the early works of Dautrebande and Philippot (1941), Tiffeneau and Beauvallet (1945) , and Curry (1947) bronchial provocation tests have been commonly used to assess the bronchial sensitivity of patients with asthma. In such tests the effects of graded doses of a bronchoconstrictor agent given by aerosol are measured until clear evidence of bronchial obstruction is obtained.
The most widely used methods for the evaluation of bronchial obstruction are forced expiratory flow measurements-forced expiratory volume at one second (FEV1), maximal mid-expiratory flow rate, peak expiratory flow rate, and partial or maximal flow-volume curves-which require a maximal respiratory manoeuvre (MRM)-that is, inspiration to total lung capacity (TLC) and expiration from TLC to residual volume (RV) . Since these manoeuvres produce acute changes in airway geometry (stretching during inspiration, compression during expiration) we considered the possibility that they may subsequently change airway sensitivity to inhaled bronchoconstrictor agents. We report here the effects of MRM on the bronchial sensitivity of asthmatic patients to inhaled carbachol.
Subjects and Methods
Five normal adults with no history or signs of chest disease or allergy and 10 patients with asthma volunteered for the study (see table) . The patients were studied during symptom-free periods and received no symptomatic medication for at least 24 hours beforehand. None of these subjects was undergoing long-term steroid therapy.
Specific airways resistance (SRaw), which is the airways resistance corrected for lung volume (Guyatt et al., 1970) , was measured in a whole-body plethysmograph at a thoracic gas volume close to functional residual capacity using the panting technique (Dubois et al., 1956 fig. 1 ). Dose-response curves were shifted to the left and the mean dose (± S.E.) of carbachol producing a twofold increase of SRaw decreased from 0-373 ± 0-041 mg in control experiments to 0(189 ± 0-046 mg in experiments with MRM, the difference being highly significant (P <0-001) when analysed using Student's paired t test.
In contrast MRM did not modify the bronchial sensitivity of normal subjects (fig. 2) MRM could increase the bronchoconstrictor effect of carbachol in several ways. It could cause modifications of pulmonary mechanics-for example, elastic recoil-changes in aerosol distribution, or changes in Po,/Pco, levels or modifications of the bronchomotor mechanisms themselves. The first three hypotheses are unlikely to be correct since these changes would also be observed in normal people, but differences could exist between normal subjects and asthmatic patients.
The fourth hypothesis is more appealing since it is commonly known that patients with asthma have abnornal airway function, as shown by the hyper-reactivity of their airways to various stimuli. MRM could enhance this hyper-reactivity (a) by a direct action on the muscle if the stretching and shortening of the airways, due to MRM, disturb the subtle mechanisms of smooth muscle contraction and relaxation or make the specific cholinergic receptors of the respiratory smooth muscle more sensitive to carbachol; (b) by releasing a prostaglandin since prostaglandins of the E and F series are released by mechanical stimuli (Piper and Vane, 1971 ) and distension (Berry et al., 1971; Said et al., 1972) (Vincent et al., 1970) and after induced bronchoconstriction (Nadel and Tierney, 1961) . These findings could help to explain the difference we observed between normal subjects and asthmatic patients.
The practical consequences of these findings must be considered since lung-function tests used to determine the bronchial sensitivity of asthmatic patients compared to controls usually involve such a sequence of MRM and inhalations of a bronchoconstrictor agent. This method probably leads to overestimation of the bronchial sensitivity of patients with asthma. Furthermore, since MRM does not equally enhance the bronchial sensitivity of all asthmatic patients the comparison of bronchial sensitivity between patients would also be biased. Thus accurate comparisons must be performed using a technique such as the measurement of airway resistance with a body plethysmograph, which does not require MRM.
Our results suggest also that situations in which spontaneous MRM occur-for example, hyperventilation due to exercisecould precipitate an attack of asthma.
